Trial Profile
Double-blind, Randomized, Multicenter Study Evaluating 200 mg Versus 600 mg of Mifegyne on Pain in Medical Termination of Pregnancy (MToP) up to 7 Weeks of Amenorreha (WA). DoMy Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Oct 2023
Price :
$35
*
At a glance
- Drugs Mifepristone (Primary)
- Indications Induced abortion
- Focus Therapeutic Use
- Acronyms DoMy
- 25 Jul 2023 Status changed from recruiting to completed.
- 08 Feb 2021 Planned End Date changed from 15 Nov 2021 to 15 Jan 2022.
- 08 Feb 2021 Planned primary completion date changed from 15 Nov 2020 to 15 Jul 2021.